Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.

The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.

Summary aggregated from MarketWatch's public RSS feed. The full reporting belongs to MarketWatch — please read it on their site.